00:00 The first immunizations with the newly approved AstraZeneca vaccine are underway in the UK. The country is scaling up mass vaccinations against COVID-19 — with a newly approved and locally developed shot. The shot was developed in cooperation with Oxford University and British pharmaceutical company AstraZeneca. It could prove to have an edge for some countries struggling to deploy mass immunizations. The shot is less expensive and it’s also easier to store. Many experts believe these qualities could make the latest vaccine more accessible for developing countries in particular.
COVID-19 latest: AstraZeneca vax rolled out +++ Germany extends shutdown till January 31 | DW News
